Nobrium is a benzodiazepam derivative tranquilizer that is indicated for the relief of symptoms associated with anxiety, depression, stress and nervous tension in adults and children aged 6 years and older. When used and dosed correctly, it can provide fast, safe and effective symptom relief for patients.
However, the use of Nobirum may be associated with a number of side effects and contraindications, such as increased fatigue, sedation, tachycardia and headache. Also, patients should pay attention to the interaction of this drug with other drugs that may increase its effect.
In the registration card, Nobirum is registered in the group of tranquilizers produced in Yugoslavia, under the trademark “ACN Galenika”. It also has similar trademarks in various countries including Germany, Sweden, Finland, Netherlands, France, Spain